Sign Out
Safety of SKYZoster has not been evaluated in pregnant women. Direct and/or indirect adverse effect related to reproduction and developmental toxicity has not been observed in animal studies. However, SKYZoster should not be administered to pregnant women since naturally occurring varicella-zoster virus infection is known to sometimes cause fetal harm. Pregnancy should be avoided for 3 months following administration of SKYZoster (refer to Contraindications).
It is not known whether varicella-zoster vaccine virus is excreted in human milk. However, since human milk transmission of maternal viral infection is established for some viruses, SKYZoster should not be administered to nursing mothers.
Continue with Google